Profound Defect of Amphiregulin Secretion by Regulatory T Cells in the Gut of HIV-Treated Patients

J Immunol. 2022 May 15;208(10):2300-2308. doi: 10.4049/jimmunol.2100725. Epub 2022 May 2.

Abstract

The persistence of a leaky gut in HIV-treated patients leads to chronic inflammation with increased rates of cardiovascular, liver, kidney, and neurological diseases. Tissue regulatory T (tTreg) cells are involved in the maintenance of intestinal homeostasis and wound repair through the IL-33 pathway. In this study, we investigated whether the persistence of gut mucosal injury during HIV infection might be explained in part by a flaw in the mechanisms involved in tissue repair. We observed an increased level of IL-33 in the gut of HIV-infected patients, which is associated with an increased level of fibrosis and a low peripheral reconstitution of CD4+ T cells. Our results showed that intestinal Treg cells from HIV-infected patients were enriched in tTreg cells prone to support tissue repair. However, we observed a functional defect in tTreg cells caused by the lack of amphiregulin secretion, which could contribute to the maintenance of intestinal damage. Our data suggest a mechanism by which the lack of amphiregulin secretion by tTreg may contribute to the lack of repair of the epithelial barrier.

MeSH terms

  • Amphiregulin* / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • Gastrointestinal Diseases / immunology
  • Gastrointestinal Diseases / virology
  • HIV Infections* / immunology
  • Humans
  • Inflammation / immunology
  • Interleukin-33 / immunology
  • Intestinal Mucosa / immunology
  • T-Lymphocytes, Regulatory* / immunology

Substances

  • AREG protein, human
  • Amphiregulin
  • Interleukin-33